Search research articles
Contact Us
Filters
Showing results (11-20 of 20) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 20 results.
Journal of Pharmaceutical Sciences
|
September 13, 2013
The use of pharmacometrics to optimize biosimilar development
Mike Dodds, Vincent Chow, Richard Markus, et al.
Urology
|
December 9, 2009
Recent time trends in the epidemiology of stage IV prostate cancer in the United States: analysis of data from the Surveillance, Epidemiology, and End Results Program
Karynsa Cetin, Jennifer L Beebe-Dimmer, Jon P Fryzek, et al.
Hospital Pediatrics
|
July 7, 2017
Quality Improvement Initiative to Increase the Use of Nasogastric Hydration in Infants With Bronchiolitis
Mythili Srinivasan, Cassandra Pruitt, Erin Casey, et al.
Journal of Oncology
|
July 10, 2009
Estimation of Cachexia among Cancer Patients Based on Four Definitions
Kathleen M Fox, John M Brooks, Shravanthi R Gandra, et al.
Advances in Therapy
|
June 12, 2019
A Review of the Totality of Evidence Supporting the Development of the First Adalimumab Biosimilar ABP 501
Richard Markus, Helen J McBride, Monica Ramchandani, et al.
JRSM Cardiovascular Disease
|
March 28, 2022
Velocity encoded mitral valve inflow cine: A novel and more reproducible method to determine cardiac rest periods during coronary magnetic resonance angiography
Richard Markus, Animesh Tandon, Munes Fares, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
November 13, 2008
Intralymphatic allergen administration renders specific immunotherapy faster and safer: a randomized controlled trial
Gabriela Senti, Bettina M Prinz Vavricka, Iris Erdmann, et al.
Pediatric Pulmonology
|
May 17, 2006
Microbiology, safety, and pharmacokinetics of aztreonam lysinate for inhalation in patients with cystic fibrosis
Ronald L Gibson, George Z Retsch-Bogart, Christopher Oermann, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
October 7, 2011
NCCN Biosimilars White Paper: regulatory, scientific, and patient safety perspectives
Andrew D Zelenetz, Islah Ahmed, Edward Louis Braud, et al.
Nature
|
July 1, 2026
Casdatifan shows durable response linked to HIF-2α biology in kidney cancer
Toni K Choueiri, Jamie Merchan, Amita Patnaik, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 20) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 20 results.
Journal of Pharmaceutical Sciences
|
September 13, 2013
The use of pharmacometrics to optimize biosimilar development
Mike Dodds, Vincent Chow, Richard Markus, et al.
Urology
|
December 9, 2009
Recent time trends in the epidemiology of stage IV prostate cancer in the United States: analysis of data from the Surveillance, Epidemiology, and End Results Program
Karynsa Cetin, Jennifer L Beebe-Dimmer, Jon P Fryzek, et al.
Hospital Pediatrics
|
July 7, 2017
Quality Improvement Initiative to Increase the Use of Nasogastric Hydration in Infants With Bronchiolitis
Mythili Srinivasan, Cassandra Pruitt, Erin Casey, et al.
Journal of Oncology
|
July 10, 2009
Estimation of Cachexia among Cancer Patients Based on Four Definitions
Kathleen M Fox, John M Brooks, Shravanthi R Gandra, et al.
Advances in Therapy
|
June 12, 2019
A Review of the Totality of Evidence Supporting the Development of the First Adalimumab Biosimilar ABP 501
Richard Markus, Helen J McBride, Monica Ramchandani, et al.
JRSM Cardiovascular Disease
|
March 28, 2022
Velocity encoded mitral valve inflow cine: A novel and more reproducible method to determine cardiac rest periods during coronary magnetic resonance angiography
Richard Markus, Animesh Tandon, Munes Fares, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
November 13, 2008
Intralymphatic allergen administration renders specific immunotherapy faster and safer: a randomized controlled trial
Gabriela Senti, Bettina M Prinz Vavricka, Iris Erdmann, et al.
Pediatric Pulmonology
|
May 17, 2006
Microbiology, safety, and pharmacokinetics of aztreonam lysinate for inhalation in patients with cystic fibrosis
Ronald L Gibson, George Z Retsch-Bogart, Christopher Oermann, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
October 7, 2011
NCCN Biosimilars White Paper: regulatory, scientific, and patient safety perspectives
Andrew D Zelenetz, Islah Ahmed, Edward Louis Braud, et al.
Nature
|
July 1, 2026
Casdatifan shows durable response linked to HIF-2α biology in kidney cancer
Toni K Choueiri, Jamie Merchan, Amita Patnaik, et al.
Page
of 2